School of Medicine
Showing 441-460 of 539 Results
-
Artem A. Trotsyuk, Ph.D.
Postdoctoral Scholar, Genetics
BioDr. Artem A. Trotsyuk is an AI Fellow in the Department of Genetics at Stanford University and an AI Special Projects Fellow at the Hoover Institution. He earned his PhD in Bioengineering and a Master’s in Computer Science with an AI specialization at Stanford, under the supervision of Dr. Geoffrey Gurtner in the Department of Surgery. He was co-advised by Dr. Zhenan Bao (Chemical Engineering), Dr. Russ Altman (Bioengineering and Medicine), and Dr. Michael Snyder (Genetics). His doctoral research focused on developing a smart bandage that integrates a closed-loop AI processing system for wound sensing and therapeutic delivery. His current work centers on evaluating AI tools in biomedicine, as well as special projects related to security, intent capture, and persona modeling.
-
Milana Trounce
Clinical Professor, Emergency Medicine
BioDr. Boukhman Trounce graduated from the University of California San Francisco (UCSF) School of Medicine and went on to complete her emergency medicine residency and fellowship in Disaster Medicine and Bioterrorism Response at Harvard Medical School. She worked with the Center for Integration of Medicine and Technology (CIMT), a consortium of Harvard teaching hospitals and MIT, where she led BioSecurity related projects in conjunction with the US State Department. She also received her MBA from Stanford Business School.
After Harvard she joined UCSF as an Assistant Professor of Emergency Medicine and was Medical Director for Disaster Response. For the past 11 years, she has been at Stanford Medical School, where she is a Clinical Professor of Emergency Medicine.
She directs the BioSecurity program at Stanford, focused on protecting society from pandemics and other threats posed by infectious organisms, with a specific emphasis on approaches to interrupting transmission of infectious organisms in various settings. The background for the approach is outlined in her briefings at the Hoover Institute (see in publications list below). Stanford BioSecurity facilitates the creation of interdisciplinary solutions by bringing together experts in biology, medicine, public health, disaster management, policy, engineering, technology, and business. https://med.stanford.edu/biosecurity/about.html
At Stanford, over the past ten years she has established and directed a class on BioSecurity and Pandemic Resilience , which examines ways of building global societal resilience to pandemics and other biothreats and has educated over a thousand students. She has also taught an online Harvard course on medical response to biological terrorism, educating thousands of physicians globally.
She has served as a spokeswoman for the American College of Emergency Physicians (ACEP) and is a founding Chair of BioSecurity at ACEP. In addition to her academic research and speaking at national conferences, she also consults nationally and internationally to healthcare systems, governments, and other organizations. -
Megan Troxell
Professor of Pathology
Current Research and Scholarly InterestsBreast pathology, renal pathology, transplant pathology, immunohistochemistry
-
Mai Thy Truong, MD
Clinical Professor, Otolaryngology (Head and Neck Surgery)
Clinical Professor (By courtesy), PediatricsBioMai Thy Truong, MD, is a Clinical Associate Professor in the department of Otolaryngology – Head and Neck Surgery, division of Pediatric Otolaryngology at Stanford Children’s Hospital. She serves as the Clinic Chief and the Fellowship Director for the division. Dr. Truong oversees a dedicated Microtia and Atresia Clinic to provide care for all the reconstructive and hearing rehabilitative needs of children with microtia and canal atresia. Dr. Truong’s other clinical interests include Vascular Anomalies, Fetal Management of critical airway (EXIT procedure), as well as Congenital head and neck masses and fistulas. Her research has explored the social impact of microtia, 3D modelling in microtia repair, the treatment of complex vascular anomalies and pediatric sleep apnea.
Dr. Truong received her Bachelor of Science from the University of California, Los Angeles in Neuroscience, graduating with honors. She went on to medical school at the University of California, Irvine. Dr Truong completed her residency training at Stanford University Hospital in Otolaryngology, Head and Neck Surgery. She did her Fellowship in Pediatric Otolaryngology at Stanford Children’s Hospital. She completed post-graduate training in Auricular reconstruction, microtia repair, in Paris, France with the world renown plastic surgeon, Dr. Francoise Firmin. Dr Truong is proficient in Spanish and conversational in Vietnamese languages. Her personal interests include musical theater and Karaoke. She strongly believes in the importance of respect for all the diversity of humankind. She is a Bay Area Native and loves the uniqueness that each niche of the Bay Area has. -
Albert Tsai, M.D., Ph.D.
Assistant Professor of Pathology
BioDr. Tsai received his undergraduate training at the University of California, Los Angeles (B.S., Biochemistry, summa cum laude), followed by combined medical and graduate training at the University of Southern California (M.D., Ph.D., Biochemistry). He completed anatomic and clinical pathology (AP/CP) residency and hematopathology fellowship at Stanford University, receiving board certification in AP/CP and hematopathology. As an instructor, he performed clinical diagnostic duties on the hematopathology service while doing postdoctoral training in the laboratory of Dr. Sean Bendall, with funding from the Damon Runyon Cancer Research Foundation.
As a physician and hematopathologist, he seeks to mechanistically dissect myelodysplastic syndromes (MDS) using highly-multiplexed immunophenotyping — mass cytometry / cytometry by time-of-flight (CyTOF) and multiplexed ion beam imaging (MIBI). MDS is an especially complex and heterogeneous disease of abnormal blood cell development with increasing prevalence and few treatments. By combining practical experience clinically diagnosing MDS, next generation single cell proteomic approaches, fundamental discoveries in the biology of MDS, and knowledge of clinical laboratory testing, we hope to develop new clinical diagnostics for personalizing MDS therapies and therapeutic monitoring.
His clinical diagnostic duties are on the hematopathology service, primarily in the diagnosis of MDS, leukemias, lymphomas, and other hematopoietic diseases from blood, bone marrow, and tissue samples.
